1. Home
  2. ACOG vs VANI Comparison

ACOG vs VANI Comparison

Compare ACOG & VANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACOG
  • VANI
  • Stock Information
  • Founded
  • ACOG 2000
  • VANI 1998
  • Country
  • ACOG Canada
  • VANI United States
  • Employees
  • ACOG N/A
  • VANI N/A
  • Industry
  • ACOG
  • VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • ACOG
  • VANI Health Care
  • Exchange
  • ACOG Nasdaq
  • VANI Nasdaq
  • Market Cap
  • ACOG 80.3M
  • VANI 68.1M
  • IPO Year
  • ACOG N/A
  • VANI 2014
  • Fundamental
  • Price
  • ACOG $9.16
  • VANI $1.15
  • Analyst Decision
  • ACOG Strong Buy
  • VANI Strong Buy
  • Analyst Count
  • ACOG 1
  • VANI 1
  • Target Price
  • ACOG $20.00
  • VANI $4.00
  • AVG Volume (30 Days)
  • ACOG 130.0K
  • VANI 136.2K
  • Earning Date
  • ACOG 08-14-2025
  • VANI 08-12-2025
  • Dividend Yield
  • ACOG N/A
  • VANI N/A
  • EPS Growth
  • ACOG N/A
  • VANI N/A
  • EPS
  • ACOG N/A
  • VANI N/A
  • Revenue
  • ACOG $2,928,654.00
  • VANI N/A
  • Revenue This Year
  • ACOG N/A
  • VANI N/A
  • Revenue Next Year
  • ACOG N/A
  • VANI N/A
  • P/E Ratio
  • ACOG N/A
  • VANI N/A
  • Revenue Growth
  • ACOG N/A
  • VANI N/A
  • 52 Week Low
  • ACOG $3.75
  • VANI $0.91
  • 52 Week High
  • ACOG $11.40
  • VANI $1.50
  • Technical
  • Relative Strength Index (RSI)
  • ACOG N/A
  • VANI 54.56
  • Support Level
  • ACOG N/A
  • VANI $1.13
  • Resistance Level
  • ACOG N/A
  • VANI $1.25
  • Average True Range (ATR)
  • ACOG 0.00
  • VANI 0.05
  • MACD
  • ACOG 0.00
  • VANI -0.01
  • Stochastic Oscillator
  • ACOG 0.00
  • VANI 29.05

About ACOG Alpha Cognition Inc. Common Stock

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

About VANI Vivani Medical Inc. (DE)

Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.

Share on Social Networks: